Description:
Levosalbutamol (100 mcg) + Ipratropium (40 mcg) Inhaler is a combination bronchodilator therapy used in the management of chronic obstructive pulmonary disease (COPD) and other obstructive airway conditions. This inhaler provides rapid and effective relief from symptoms such as coughing, wheezing, chest tightness, and shortness of breath by relaxing the airway muscles and improving airflow to the lungs.
Therapeutic Uses:
Maintenance and symptomatic treatment of COPD, including chronic bronchitis and emphysema
Adjunctive treatment in asthma where dual bronchodilation is required
Mechanism of Action:
Levosalbutamol is a short-acting beta-2 adrenergic agonist that relaxes bronchial smooth muscle, resulting in quick bronchodilation and relief from bronchospasm.
Ipratropium is an anticholinergic that inhibits muscarinic receptors, reducing bronchoconstriction and airway secretions.
Together, they provide complementary mechanisms of action for enhanced respiratory relief.
Dosage Form:
Metered-Dose Inhaler (MDI)
Strength:
Levosalbutamol 100 mcg
Ipratropium 40 mcg per actuation
Prescription Status:
Prescription-only medication
Note:
This inhaler is intended for regular use as directed by a physician and is not a substitute for long-term anti-inflammatory therapy. Proper inhalation technique is essential for optimal efficacy. Use under the guidance of a healthcare professional.
Would you like this version tailored for pharmacy listings or export documentation?
